CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 15,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure · Other events
- 4 Option exercise Chief Scientific Officer acquired 15,477 shares (option exercise)
- 4 Open-market sale Director sold 150,000 shares at an average $57.69 ($8,653,890)
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 8-K Event Other events
- 4 Open-market sale Chief Executive Officer sold 5,000 shares at an average $60.00 ($300,016)
- 8-K Event Material agreement · Results of operations
- 424B5 Offering Prospectus
- 4 Open-market sale Chief Executive Officer sold 5,000 shares at an average $53.88 ($269,388)
- 424B5 Offering Prospectus
- S-3ASR Offering Registration Statement
- 8-K Event Other events
- 4 Open-market sale Chief Scientific Officer sold 3,366 shares at an average $45.06 ($151,688)
Page 22 of 33 · 660 filings